AdimFlu-S

BIOLOGICAL3 trials

Sponsors

Adimmune Corporation, National Cheng-Kung University Hospital

Conditions

Influenza

Phase 4

Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old

CompletedNCT01355172

Adimmune CorporationInfluenza

Start: 2010-11-30Updated: 2012-07-16

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients

National Cheng-Kung University HospitalInfluenza

Start: 2011-10-31End: 2012-03-31Target: 300Updated: 2012-01-19

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

CompletedNCT01752881

Adimmune CorporationInfluenza

Start: 2012-08-31End: 2012-09-30Updated: 2012-12-19